These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39054955)

  • 21. Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
    Xie Y; Peng Z; Shi M; Ji M; Guo H; Shi H
    Mol Med Rep; 2014 Nov; 10(5):2346-50. PubMed ID: 25118792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
    Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P
    PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis.
    Qin Y; Li W; Long Y; Zhan Z
    Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.
    Zhang Y; Tao L; Fan LX; Huang K; Luo HM; Ge H; Wang X; Wang Q
    Mol Med Rep; 2019 Mar; 19(3):2287-2296. PubMed ID: 30664215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ubiquitin‑specific protease 14 promotes connexin 32 internalization and counteracts cisplatin cytotoxicity in human ovarian cancer cells.
    Luo H; Wang X; Ge H; Zheng N; Peng F; Fu Y; Tao L; Wang Q
    Oncol Rep; 2019 Sep; 42(3):1237-1247. PubMed ID: 31322234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
    Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
    Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression.
    Zhang L; He L; Zhang H; Chen Y
    Cell Physiol Biochem; 2018; 47(4):1432-1441. PubMed ID: 29940575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer
    Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
    Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.
    Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F
    Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.
    Seino M; Okada M; Sakaki H; Takeda H; Watarai H; Suzuki S; Seino S; Kuramoto K; Ohta T; Nagase S; Kurachi H; Kitanaka C
    Oncol Rep; 2016 Jan; 35(1):593-601. PubMed ID: 26534836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.
    Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H
    Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.
    Rao YM; Shi HR; Ji M; Chen CH
    J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):567-572. PubMed ID: 23904379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.
    Jin L; Huo Y; Zheng Z; Jiang X; Deng H; Chen Y; Lian Q; Ge R; Deng H
    Mol Cell Proteomics; 2014 Nov; 13(11):3138-51. PubMed ID: 25096996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.